Diet and exercise must be considered as the first line of treatment, however if they fail to correct metabolic signalling, IGF-1 therapy seems to be promising at metabolic harmonisation
Protocol : BPC-157: 500 mcg/day (near injury or systemic) CJC-1295 w/ DAC: 2 mg twice per week Ipamorelin: 100200 mcg, 12x/day Duration: 68 weeks max Stacking Summary Potential Side Effects and Safety Profile of BPC-157 Compared to most performance-enhancing drugs, peptides, or even over-the-counter recovery aids, BPC-157 is remarkably well-tolerated
Why Order GHK-Cu from Bluewell Peptides
In animal studies, no observable adverse effects were reported, and the compound did not affect food intake or inhibit related enzymes
Additionally , appropriate storage conditions and standardized handling procedures help preserve peptide stability and experimental integrity